Literature DB >> 16322528

The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease.

Jamila Khallou-Laschet1, Giuseppina Caligiuri, Emilie Groyer, Emanuel Tupin, Anh-Thu Gaston, Bruno Poirier, Mitchell Kronenberg, José L Cohen, David Klatzmann, Srini V Kaveri, Antonino Nicoletti.   

Abstract

OBJECTIVE: The mechanism by which T cells exert a proatherogenic potential is unclear. In order to determine whether this potential requires their replication, we crossed atherosclerosis-prone apolipoprotein E knockout mice (ApoE degrees) with transgenic mice in which exclusive and conditional ablation of dividing T cells relies on their specific expression of the herpes simplex type 1 thymidine kinase (TK) suicide gene. METHODS AND
RESULTS: We first showed that conalbumin-immunized ApoE degrees TK mice mounted a significant immune response to the antigen that was fully and specifically blocked by an in vivo ganciclovir (GCV) treatment. Next, ApoE degrees TK mice and ApoE degrees mice were treated or not with GCV either during the first 4 weeks (GCV 1 to 4w), the last 4 weeks (GCV 5 to 8w), or during 8 weeks (GCV 1 to 8w). Strikingly, ApoE degrees TK mice displayed a dramatic decrease in lesion development in the GCV 1 to 8w and GCV 5 to 8w groups, whereas the GCV had no effect when administered during the first 4 weeks. In protected mice, the inflammatory parameters in lesions, the percentage of CD69+ CD3+ splenocytes, and the circulating natural killer T cells were reduced.
CONCLUSIONS: The present study, therefore, shows that the proatherogenic potential of T cells is crucial in the progression of fatty streaks to mature plaques and requires cell division.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322528     DOI: 10.1161/01.ATV.0000198401.05221.13

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma?

Authors:  C D Schwindt; F Zaldivar; L Wilson; S-Y Leu; J Wang-Rodriguez; P J Mills; D M Cooper
Journal:  Br J Sports Med       Date:  2006-10-04       Impact factor: 13.800

2.  Macrophage plasticity in experimental atherosclerosis.

Authors:  Jamila Khallou-Laschet; Aditi Varthaman; Giulia Fornasa; Caroline Compain; Anh-Thu Gaston; Marc Clement; Michaël Dussiot; Olivier Levillain; Stéphanie Graff-Dubois; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 3.  The role of the adventitia in vascular inflammation.

Authors:  Kathryn Maiellaro; W Robert Taylor
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

Review 4.  Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More.

Authors:  Marie Le Borgne; Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 5.  Is CD69 an effective brake to control inflammatory diseases?

Authors:  Roberto González-Amaro; José R Cortés; Francisco Sánchez-Madrid; Pilar Martín
Journal:  Trends Mol Med       Date:  2013-08-13       Impact factor: 11.951

6.  Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans.

Authors:  Dolf Segers; Jonathan A Lipton; Pieter J M Leenen; Caroline Cheng; Dennie Tempel; Gerard Pasterkamp; Frans L Moll; Rini de Crom; Rob Krams
Journal:  Int J Inflam       Date:  2011-11-13

Review 7.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

8.  Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development.

Authors:  Janine van Duijn; Maaike J M de Jong; Naomi Benne; Romain J T Leboux; Marieke E van Ooijen; Nicky Kruit; Amanda C Foks; Wim Jiskoot; Ilze Bot; Johan Kuiper; Bram Slütter
Journal:  Cardiovasc Res       Date:  2021-12-17       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.